| Related Knowledge Base Chapters|
| Journal Articles|
|A brief history of the global effort to develop a preventive HIV
Esparza J. Vaccine. 2013 May 21.
|Harnessing CD4+ T cell responses in HIV vaccine development|
Streeck H, D'Souza MP, Littman DR, et al. Nat Med. 2013
|Accelerating the development of a safe and effective HIV vaccine:
HIV vaccine case study for the Decade of Vaccines|
Koff WC, Russell ND, Walport M, et al.
|Recent advances in research of HIV infection: implications of
viral and host genetics on treatment and prevention|
Haaland RE, Johnson JA, Tang J. Public Health Genomics.
|HIV vaccine development: strategies for preclinical and clinical
Shapiro SZ. AIDS Res Hum Retroviruses. 2013 Mar 8.
|In pursuit of an HIV vaccine: designing efficacy trials in the
context of partially effective non-vaccine prevention modalities|
Janes H, Gilbert P, Buchbinder S, et al. AIDS Res Hum Retroviruses. 2013
|The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen
induces antibodies that target conserved regions within the V2 loop
Karasavvas N, Billings E, Rao M, et al. AIDS Res Hum Retroviruses. 2012
|Rational design of vaccines for AIDS and influenza|
Nabel GJ. Trans Am Clin Climatol Assoc. 2012;123:9-15; discussion
|HIV-1 vaccine trials: evolving concepts and designs|
Sanou MP, De Groot AS, Murphey-Corb M, et al. Open AIDS J.
|HIV vaccines: progress to date.|
Munier CM, Andersen CR, Kelleher AD. Drugs. 2011 Mar
| Guidelines and Best Practices|
| Conference Reports and Proceedings|
| Presentations, Interviews, and Roundtable Discussions|
| Research Summaries|
| Online Books and Chapters|
| Clinician Support Tools|
|Preventative HIV Vaccine Trials|
A chart from AVAC listing the ongoing vaccine trials, with key information
such as phase, regimen, current status, and number of enrollees; April 2013.
| Slide Sets|
|AIDS Vaccines: The Basics|
An introductory slide set with basic concepts, an overview of research
status and recent developments; AVAC; April 2013. [PPT, 4.82MB]
|AIDS Vaccines: Then and Now|
Graphical comparisons of numbers of AIDS vaccine trial sites,
participants, and investment over the years; AVAC; May 2012. [PPT,
|AIDS Vaccine Advocacy Coalition|
(AVAC) Advocacy for developing HIV/AIDS vaccines. Site features Vaccine handbook, news articles, official reports, FAQs, and activist manifestos.
|Capital Area Vaccine Effort|
A volunteer panel of individuals from the general public and communities affected by AIDS. Assists and advises vaccine trials in the metropolitan Washington, DC area.
|Global Alliance for Vaccines and Immunization|
Works to expand access to existing vaccines in the developing world and accelerate research on needed vaccines, including HIV vaccines.
|International AIDS Vaccine Initiative|
(IAVI) Works to speed the development and distribution of preventive AIDS vaccines by funding research, mobilizing support through advocacy and education, and encouraging private sector participation in AIDS vaccine development.
|National AIDS Trust (UK)|
UK's leading policy development and advocacy AIDS organisation. Includes a prevention technologies annual update.
|WHO-UNAIDS HIV Vaccine Initiative|
(HVI) Advocacy, information, education, and policy dialogue.
| Vaccine Company Pages|
| Clinical Trial Databases|
AIDSinfo Vaccine Information|
A service of the U.S. Department of Health and Human Services. Includes searchable listings of clinical trials for preventive and therapeutic HIV vaccines, as well as a glossary, HIV vaccine news, and links to related web sites.
|HIV/SIV Vaccine Trials Database|
A project of the Los Alamos National Laboratory.
|International AIDS Vaccine Initiative (IAVI)|
Works to speed the development and distribution of preventive AIDS vaccines by funding research, mobilizing support through advocacy and education, and encouraging private sector participation in AIDS vaccine development.
| Document Collections|